AIRS Medical bags $20M to take more global markets
Korean medical AI company AIRS Medical has raked in $20 million in a Series C funding round led by BSK Investment and Shinyoung Securities.
Based on a press statement, the company will use its fresh funds to continue its global expansion and invest in R&D.
Last year, AIRS Medical launched its flagship product, SwiftMR, in the United States...
Best Practice integrates genAI
Practice management system brand Best Practice Software is set to introduce a new transcription tool run by generative AI.
The company recently partnered with Lyrebird Health to integrate the Lyrebird Scribe into its software offering. The tool automatically generates medical documentation such as patient notes during the consultation process, filters out...
Taiwan clears VUNO's AI fundus analysis tool
South Korean firm VUNO has gained the approval of Taiwan's Food and Drug Administration to market its AI fundus analysis software.
VUNO Med-Fundus AI analyses images of the fundus to quickly detect locations of lesions indicative of retinal diseases, including diabetic retinopathy, macular disease and glaucoma.
This latest certification follows Taiwan...
Medical AI startup AIRS Medical from South Korea has raised $20 million in a Series B funding round participated by its new investors Q Capital Partners and Hanwha Life and its existing investor Klim Ventures.
WHAT IT DOES
Founded in 2018, the startup offers AI-based diagnostic tests and robotic technologies that improve both patient and healthcare provider experience.
Its flagship product,...
